Literature DB >> 11083876

Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes.

S Frantz1, R A Kelly, T Bourcier.   

Abstract

Growing evidence from patients with heart failure and from experimental animal models implicates effectors of innate immunity in the pathogenesis of this syndrome. The expression of the innate immunity signaling protein, Toll-like receptor 4 (TLR4), is increased in cardiac myocytes in situ and in failing myocardium, but the mechanism by which TLRs may be activated in the failing heart remains unclear. We report that TLR2, which is expressed in cardiac myocytes, participates in the response of these cells to oxidative stress, a major contributor to the pathogenesis of cardiac dysfunction. Hydrogen peroxide increased nuclear factor kappaB (NF-kappaB) activation in Chinese hamster ovary fibroblasts that overexpress TLR2 but not in normal or TLR4-overexpressing Chinese hamster ovary cells, an effect that was abrogated by an alpha-TLR2 antibody. In neonatal rat ventricular myocytes, the alpha-TLR2 antibody inhibited hydrogen peroxide-induced nuclear translocation of NF-kappaB and activator protein-1 (AP-1). Inhibition of TLR2 had no effect on tumor necrosis factor alpha-induced NF-kappaB or AP-1 activation, on the DNA binding of the basal transcription factor Oct-1, or on hydrogen peroxide-induced phosphorylation of p38 MAP kinase. Importantly, oxidative stress-induced cytotoxicity was enhanced by blocking TLR2. Given the importance of cytotoxicity and apoptosis to the pathology of the ischemic heart, an anti-apoptotic effect of TLR2 in cardiac myocytes exposed to elevated levels of ROS may limit further cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083876     DOI: 10.1074/jbc.M009160200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

Review 1.  Toll receptors: a central element in innate immune responses.

Authors:  Thierry Vasselon; Patricia A Detmers
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 2.  Therapeutic targeting of innate immunity in the failing heart.

Authors:  Veli K Topkara; Sarah Evans; Weili Zhang; Slava Epelman; Lora Staloch; Philip M Barger; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2010-11-10       Impact factor: 5.000

3.  Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury.

Authors:  Aaron M Abarbanell; Yue Wang; Jeremy L Herrmann; Brent R Weil; Jeffrey A Poynter; Mariuxi C Manukyan; Daniel R Meldrum
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

Review 4.  Toll-like receptors in defense and damage of the central nervous system.

Authors:  Rajagopal N Aravalli; Phillip K Peterson; James R Lokensgard
Journal:  J Neuroimmune Pharmacol       Date:  2007-04-03       Impact factor: 4.147

5.  Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury.

Authors:  Stefan Frantz; Jochen Tillmanns; Peter J Kuhlencordt; Isabel Schmidt; Anna Adamek; Charlotte Dienesch; Thomas Thum; Steve Gerondakis; Georg Ertl; Johann Bauersachs
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

6.  Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cells.

Authors:  Mark J Paul-Clark; Rosalinda Sorrentino; Lucy K Bailey; Shiranee Sriskandan; Jane A Mitchell
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

Review 7.  NOX enzymes and Toll-like receptor signaling.

Authors:  Eric Ogier-Denis; Sanae Ben Mkaddem; Alain Vandewalle
Journal:  Semin Immunopathol       Date:  2008-05-21       Impact factor: 9.623

Review 8.  The role of reactive oxygen species in myocardial redox signaling and regulation.

Authors:  Demetrios Moris; Michael Spartalis; Eleni Tzatzaki; Eleftherios Spartalis; Georgia-Sofia Karachaliou; Andreas S Triantafyllis; Georgios I Karaolanis; Diamantis I Tsilimigras; Stamatios Theocharis
Journal:  Ann Transl Med       Date:  2017-08

Review 9.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

10.  Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction.

Authors:  Stefan Frantz; Kai Hu; Julian Widder; Barbara Bayer; Catharina Clara Witzel; Isabel Schmidt; Paolo Galuppo; Jörg Strotmann; Georg Ertl; Johann Bauersachs
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.